105 related articles for article (PubMed ID: 6489441)
41. Mesencephalic sites of action of an enkephalin analogue (D-Met2, Pro5)-enkephalinamide and naloxone on the anterior pituitary of male rats.
Molnár J; Halász B
Brain Res; 1991 Nov; 563(1-2):270-2. PubMed ID: 1786539
[TBL] [Abstract][Full Text] [Related]
42. Antiglucocorticoid RU 38486 attenuates retention of a behaviour and disinhibits the hypothalamic-pituitary adrenal axis at different brain sites.
De Kloet ER; De Kock S; Schild V; Veldhuis HD
Neuroendocrinology; 1988 Feb; 47(2):109-15. PubMed ID: 3344063
[TBL] [Abstract][Full Text] [Related]
43. Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesic.
Chipkin RE; Berger JG; Billard W; Iorio LC; Chapman R; Barnett A
J Pharmacol Exp Ther; 1988 Jun; 245(3):829-38. PubMed ID: 3164388
[TBL] [Abstract][Full Text] [Related]
44. Effect of naloxone and D-met2-pro5-enkephalinamide treatment on the DNA synthesis in the developing rat brain.
Vértes Z; Melegh G; Vértes M; Kovács S
Life Sci; 1982 Jul; 31(2):119-26. PubMed ID: 7121198
[TBL] [Abstract][Full Text] [Related]
45. Differential effects of D-Ala2 analogues of enkephalins on substance P-induced analgesia in rodents.
Naranjo JR; Del Rio J
Eur J Pharmacol; 1982 Aug; 82(3-4):213-6. PubMed ID: 6182008
[TBL] [Abstract][Full Text] [Related]
46. Effects of beta-adrenergic blocking agents on specific binding of [3H]D-Ala2-Met5-enkephalinamide and [3H]naloxone.
Takayama H; Ogawa N; Asanuma M; Hirata H; Ogura T; Ota Z
Acta Med Okayama; 1991 Oct; 45(5):295-9. PubMed ID: 1684486
[TBL] [Abstract][Full Text] [Related]
47. Local and distal effects induced by unilateral striatal application of opiates in the absence or in the presence of naloxone on the release of dopamine in both caudate nuclei and substantiae nigrae of the cat.
Chesselet MF; Chéramy A; Reisine TD; Lubetzki C; Desban M; Glowinski J
Brain Res; 1983 Jan; 258(2):229-42. PubMed ID: 6824913
[TBL] [Abstract][Full Text] [Related]
48. Effects of thiorphan on the antinociceptive actions of intrathecal [D-Ala2,Met5] enkephalin.
Yaksh TL; Harty GJ
Eur J Pharmacol; 1982 Apr; 79(3-4):293-300. PubMed ID: 7047177
[TBL] [Abstract][Full Text] [Related]
49. [Changes in the potentiation effect of [D-Ala2, Met5]-enkephalin on pressor responses to l-adrenaline in adrenal-enucleated rats].
Izumi M
Nihon Yakurigaku Zasshi; 1988 May; 91(5):301-8. PubMed ID: 3410377
[TBL] [Abstract][Full Text] [Related]
50. Effects of superfusion of morphine and enkephalins on the activity of single units in the spinal trigeminal nucleus and cuneate nucleus of cat.
Wong CL; Chan YS; Cheung YM; Hwang JC; Poon PW; Wong TM
Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):351-5. PubMed ID: 3736280
[TBL] [Abstract][Full Text] [Related]
51. Modulation of dopamine release in rat striatal slices by delta opiate agonists.
Lubetzki C; Chesselet MF; Glowinski J
J Pharmacol Exp Ther; 1982 Aug; 222(2):435-40. PubMed ID: 6284911
[TBL] [Abstract][Full Text] [Related]
52. Plasma norepinephrine, epinephrine and dopamine responses to intracerebral administration of a met-enkephalin analog, D-ala2-met-enkephalinamide, in rats.
Van Loon GR; Appel NM
Neuroendocrinology; 1981 Sep; 33(3):153-7. PubMed ID: 6270584
[TBL] [Abstract][Full Text] [Related]
53. CNS involvement in the antisecretory action of [Met5]enkephalinamide on the rat intestine.
Brown DR; Miller RJ
Eur J Pharmacol; 1983 Jun; 90(4):441-4. PubMed ID: 6884432
[TBL] [Abstract][Full Text] [Related]
54. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
55. Adrenalectomy and dexamethasone differentially affect postswim antinociception in mice selectively bred for high and low stress-induced analgesia.
Panocka I; Sadowski B; Marek P
Physiol Behav; 1987; 40(5):597-601. PubMed ID: 3671524
[TBL] [Abstract][Full Text] [Related]
56. Stimulation of opiate receptors in the dorsal pontine tegmentum inhibits reflex contraction of the urinary bladder.
Willette RN; Morrison S; Sapru HN; Reis DJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):403-9. PubMed ID: 2891844
[TBL] [Abstract][Full Text] [Related]
57. Radioiodinated [D-Ala2, Met5] enkephalin. Preparation, purification by high performance liquid chromatography and binding characteristics.
Yeung CW
Int J Pept Protein Res; 1984 Dec; 24(6):636-44. PubMed ID: 6099338
[TBL] [Abstract][Full Text] [Related]
58. Effects of intraventricular morphine and enkephalins on schedule-controlled behavior in nondependent, morphine-dependent and postdependent rats.
Brady LS; Holtzman SG
J Pharmacol Exp Ther; 1981 Nov; 219(2):344-51. PubMed ID: 7197301
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the respiratory activity of (D-Ala2)methionine-enkephalinamide.
Zobrist RH; Allerton HW; Isom GE
Eur J Pharmacol; 1981 Mar; 70(2):121-8. PubMed ID: 6790294
[TBL] [Abstract][Full Text] [Related]
60. (D-Met2,Pro5)-enkephalinamide-induced blockade of ovulation and its reversal by naloxone in the rat.
Köves K; Marton J; Molnár J; Halász B
Neuroendocrinology; 1981 Feb; 32(2):82-6. PubMed ID: 6782500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
